Sensyne Health plc reported earnings results for the half year ended October 31, 2021. For the half year, the company reported sales was GBP 1.03 million compared to GBP 2.32 million a year ago. Net loss was GBP 21.12 million compared to GBP 13.81 million a year ago.

Basic loss per share from continuing operations was GBP 0.13 compared to GBP 0.11 a year ago.